0,882  0,003  Skin irritative effect
0,758  0,006  Antiasthmatic
0,750  0,008  Respiratory analeptic
0,738  0,007  Toll-Like receptor 7 agonist
0,732  0,007  Toll-Like receptor agonist
0,707  0,005  Antineoplastic enhancer
0,728  0,026  Antiinflammatory
0,668  0,009  Analeptic
0,666  0,036  Apoptosis agonist
0,620  0,006  UGT1A4 substrate
0,587  0,012  Cardiovascular analeptic
0,578  0,005  Antieczematic atopic
0,566  0,018  Immunosuppressant
0,555  0,020  Antiallergic
0,539  0,017  Cardioprotectant
0,539  0,019  Spasmolytic
0,550  0,038  Transcription factor NF kappa B inhibitor
0,527  0,029  Teratogen
0,520  0,041  TNF expression inhibitor
0,492  0,016  Antipyretic
0,488  0,023  Sensitization
0,498  0,034  Antipruritic, allergic
0,465  0,009  Hair growth stimulant
0,477  0,026  Antifungal
0,479  0,030  CYP2C19 substrate
0,449  0,006  Pneumotoxic
0,454  0,011  P-glycoprotein inhibitor
0,475  0,033  Embryotoxic
0,450  0,020  Nitric oxide antagonist
0,446  0,030  Antipsoriatic
0,444  0,029  Antineoplastic (pancreatic cancer)
0,420  0,009  UGT2B7 substrate
0,422  0,019  Psychostimulant
0,410  0,010  Antiacne
0,430  0,038  Antihypercholesterolemic
0,405  0,016  Antihelmintic
0,433  0,053  CYP2C9 substrate
0,403  0,024  Antiparasitic
0,411  0,033  Chemoprotective
0,390  0,015  Non-steroidal antiinflammatory agent
0,397  0,027  Tumour necrosis factor alpha release inhibitor
0,405  0,038  ICAM1 expression inhibitor
0,425  0,059  Antineoplastic (lung cancer)
0,385  0,021  Sedative
0,394  0,033  NOS2 expression inhibitor
0,416  0,058  CYP3A4 substrate
0,400  0,044  Hepatic disorders treatment
0,387  0,031  Proliferative diseases treatment
0,371  0,017  Contraceptive
0,360  0,017  Antiseptic
0,369  0,028  Vascular (periferal) disease treatment
0,358  0,018  Platelet adhesion inhibitor
0,402  0,063  Antileukemic
0,360  0,021  UGT1A1 substrate
0,342  0,013  Acaricide
0,382  0,054  Antithrombotic
0,388  0,064  Ulceration
0,408  0,086  Antidiabetic
0,408  0,086  Cyclophilin D inhibitor
0,361  0,041  Cytotoxic
0,363  0,045  CTGF expression inhibitor
0,319  0,007  Expectorant
0,332  0,028  Antiparkinsonian, rigidity relieving
0,326  0,027  RNA-directed DNA polymerase inhibitor
0,335  0,037  Chemopreventive
0,348  0,057  Apoptosis antagonist
0,367  0,080  GST A substrate
0,297  0,010  Antifungal enhancer
0,329  0,043  Hypoglycemic
0,297  0,011  UGT2B9 substrate
0,341  0,057  Antineoplastic (melanoma)
0,298  0,017  Protein kinase stimulant
0,300  0,022  Antipruritic, non-allergic
0,319  0,042  Mutagenic
0,342  0,068  Cholesterol antagonist
0,327  0,053  Antioxidant
0,360  0,093  Antineoplastic (breast cancer)
0,286  0,023  Anesthetic
0,298  0,035  UDP-glucuronosyltransferase substrate
0,289  0,033  Hepatoprotectant
0,290  0,040  Gastrin inhibitor
0,259  0,012  ATPase inhibitor
0,284  0,038  Abortion inducer
0,262  0,016  Antihyperlipoproteinemic
0,312  0,069  Antineoplastic (ovarian cancer)
0,268  0,025  Carcinogenic, group 3
0,298  0,057  Transcription factor STAT inhibitor
0,296  0,055  Transcription factor STAT3 inhibitor
0,283  0,043  Antihypertriglyceridemic
0,248  0,009  Microtubule formation inhibitor
0,292  0,053  GST M1-1 substrate
0,240  0,005  Actinic keratosis treatment
0,289  0,054  Interleukin agonist
0,284  0,049  DNA synthesis inhibitor
0,244  0,010  Choleretic
0,258  0,027  Interferon gamma antagonist
0,238  0,008  Mucolytic
0,308  0,083  FMO1 substrate
0,241  0,017  Antitussive
0,327  0,104  Atherosclerosis treatment
0,258  0,035  Eye irritation, high
0,268  0,051  Carcinogenic
0,226  0,015  Farnesoid X receptor antagonist
0,253  0,045  VCAM1 expression inhibitor
0,269  0,064  5 Hydroxytryptamine uptake stimulant
0,298  0,093  Calcium channel activator
0,273  0,074  UGT2B4 substrate
0,237  0,038  Lipocortins synthesis antagonist
0,217  0,019  Arachidonic acid antagonist
0,205  0,009  TRPA1 agonist
0,262  0,068  Myocardial infarction treatment
0,227  0,033  Prostate disorders treatment
0,264  0,073  DNA damaging
0,340  0,153  Caspase 9 stimulant
0,197  0,018  Alcohol dehydrogenase substrate
0,248  0,070  Tyrosine 3 hydroxylase inhibitor
0,248  0,071  Angiogenesis stimulant
0,199  0,027  Cholesterol synthesis inhibitor
0,214  0,042  Antiviral (Herpes)
0,259  0,090  Antihypoxic
0,186  0,017  Contraceptive female
0,248  0,080  Antineoplastic (renal cancer)
0,239  0,072  Cytostatic
0,175  0,010  Ca2+-transporting ATPase inhibitor
0,236  0,072  Antineoplastic (lymphoma)
0,267  0,105  AR expression inhibitor
0,163  0,005  ATPase (Vacuolar H+) inhibitor
0,178  0,020  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,167  0,011  GST T1-1 substrate
0,310  0,154  5 Hydroxytryptamine release inhibitor
0,164  0,012  Anabolic
0,171  0,020  Aldehyde dehydrogenase substrate
0,193  0,044  Melanin inhibitor
0,215  0,066  Anesthetic general
0,232  0,083  Antineoplastic (glioma)
0,257  0,111  Antineoplastic (brain cancer)
0,149  0,007  5-Alpha-reductase inhibitor
0,229  0,089  Antineoplastic (non-small cell lung cancer)
0,289  0,150  Analgesic
0,190  0,051  Antirickettsial
0,164  0,029  GABA C receptor agonist
0,242  0,110  NOS3 expression inhibitor
0,183  0,052  UGT2B10 substrate
0,238  0,109  Antineoplastic (colorectal cancer)
0,147  0,021  Acetylcholine nicotinic antagonist
0,205  0,081  Antialcoholic
0,213  0,090  Antihypotensive
0,165  0,041  Adenylate cyclase stimulant
0,126  0,004  Acetyl-CoA transferase 2 inhibitor
0,130  0,009  Anticholelithogenic
0,136  0,016  Ornithine decarboxylase inhibitor
0,150  0,030  HDL-cholesterol increasing
0,226  0,107  Antineoplastic (colon cancer)
0,274  0,155  Antibacterial
0,149  0,031  Antineoplastic antibiotic
0,203  0,086  Antiulcerative
0,162  0,048  Alpha-N-acetylglucosaminidase inhibitor
0,232  0,119  Prostate cancer treatment
0,221  0,108  Lipoprotein disorders treatment
0,149  0,043  Autism spectrum disorders treatment
0,118  0,013  Glycine receptor agonist
0,174  0,069  Toxic, respiratory center
0,125  0,023  Antifungal (Aspergillus)
0,224  0,122  CYP2D6 substrate
0,170  0,068  Antihelmintic (Nematodes)
0,238  0,141  Sodium/bile acid cotransporter inhibitor
0,143  0,046  Vanilloid 1 agonist
0,201  0,106  Antineoplastic (liver cancer)
0,152  0,056  Antifungal (Cryptococcus)
0,179  0,084  Sepsis treatment
0,160  0,066  Antiviral (Influenza A)
0,209  0,115  Immunostimulant
0,100  0,006  Postcoital contraceptive
0,155  0,061  Cell wall synthesis inhibitor
0,114  0,020  Na+ K+ transporting ATPase inhibitor
0,110  0,017  Narcotic antagonist
0,144  0,052  Anesthetic local
0,138  0,045  Carcinogenic, group 2B
0,191  0,101  Hypolipemic
0,137  0,047  Menstruation disorders treatment
0,183  0,094  Neurotrophic factor enhancer
0,129  0,041  UGT2B1 substrate
0,119  0,031  Paget's disease treatment
0,121  0,033  UGT2B11 substrate
0,129  0,044  GABA C receptor antagonist
0,090  0,006  Retinoid X receptor agonist
0,120  0,037  DNA directed RNA polymerase inhibitor
0,109  0,027  Antiprotozoal activity enhancer
0,217  0,139  Bone diseases treatment
0,127  0,050  Photosensitizer
0,135  0,058  DNA polymerase I inhibitor
0,107  0,032  Antibiotic
0,136  0,061  Cyclooxygenase 3 inhibitor
0,111  0,036  Antispirochetal
0,145  0,070  Antiparkinsonian, tremor relieving
0,101  0,027  GABA aminotransferase inhibitor
0,097  0,025  Neuronal nicotinic receptor antagonist
0,134  0,062  Cholinergic antagonist
0,134  0,064  Retinoprotector
0,129  0,060  Alkylator
0,077  0,008  Pregnane X receptor antagonist
0,080  0,014  Aconitate hydratase inhibitor
0,201  0,136  Antiepileptic
0,084  0,020  Glutamate (mGluR6) antagonist
0,073  0,008  Retinoid X alpha receptor agonist
0,206  0,141  Antineoplastic (multiple myeloma)
0,128  0,064  Acetylcholine antagonist
0,106  0,042  Acetylcholine M3 receptor agonist
0,105  0,043  Androgen antagonist
0,069  0,007  Microtubule stabilization
0,066  0,004  Tubulin agonist
0,102  0,046  Triose-phosphate isomerase inhibitor
0,157  0,100  Succinate dehydrogenase inhibitor
0,060  0,005  Vanilloid 3 antagonist
0,094  0,041  Vanilloid agonist
0,073  0,020  Nicotinic receptor alpha7 subunit antagonist
0,171  0,118  Antiglaucomic
0,071  0,020  Lipocortins synthesis agonist
0,159  0,111  Antineoplastic (glioblastoma multiforme)
0,109  0,062  Ferrochelatase inhibitor
0,118  0,072  Growth stimulant
0,167  0,122  VEGF expression inhibitor
0,056  0,012  GABA uptake inhibitor
0,103  0,058  UDP-glucose 4-epimerase inhibitor
0,141  0,096  Prostatic (benign) hyperplasia treatment
0,130  0,086  UGT2B15 substrate
0,075  0,033  SULT2A1 substrate
0,053  0,011  Kainate receptor agonist
0,067  0,026  Protein 50S ribosomal subunit inhibitor
0,081  0,039  Vanilloid 4 agonist
0,096  0,055  ABCA1 expression enhancer
0,211  0,171  Interleukin 2 agonist
0,139  0,100  Macular degeneration treatment
0,042  0,004  Vanilloid 2 agonist
0,097  0,059  Prolactin inhibitor
0,215  0,177  Antiprotozoal (Plasmodium)
0,080  0,043  CDC25A inhibitor
0,085  0,049  Glycine receptor antagonist
0,090  0,054  Antineoplastic alkaloid
0,043  0,007  Elastase 3A inhibitor
0,043  0,007  Elastase 3B inhibitor
0,043  0,007  Elastase 2B inhibitor
0,117  0,081  M17 leucyl aminopeptidase inhibitor
0,144  0,109  Tumour necrosis factor antagonist
0,065  0,033  Potassium channel Kv1.5 blocker
0,105  0,073  SULT1A1 substrate
0,084  0,053  T cell inhibitor
0,034  0,004  Progesterone receptor B antagonist
0,108  0,079  Beta amyloid protein antagonist
0,065  0,036  Androgen agonist
0,050  0,022  Parathyroid hormone antagonist
0,130  0,103  Sigma receptor agonist
0,061  0,035  Ryanodine receptor antagonist
0,055  0,029  Anesthetic inhalation
0,049  0,024  Opioid kappa receptor agonist
0,131  0,107  Muscle relaxant
0,089  0,065  Restless leg syndrome treatment
0,092  0,068  Bile acid receptor antagonist
0,090  0,067  Antiviral (Rhinovirus)
0,244  0,222  Alzheimer's disease treatment
0,149  0,130  Anticonvulsant
0,054  0,035  Acetyl-CoA transferase inhibitor
0,126  0,107  UGT1A3 substrate
0,062  0,043  Antimycoplasmal
0,093  0,075  Antiviral (Poxvirus)
0,109  0,091  CNS active muscle relaxant
0,110  0,092  Coagulant
0,027  0,010  Prostaglandin F2 alpha agonist
0,113  0,096  Cocaine dependence treatment
0,039  0,023  Progesterone antagonist
0,121  0,105  SULT1A3 substrate
0,096  0,079  Excitatory amino acid transporter EAAC1 inhibitor
0,066  0,052  Elastase 1 inhibitor
0,073  0,059  Keratolytic
0,100  0,087  Proteasome inhibitor
0,169  0,156  Nitric-oxide synthase stimulant
0,132  0,119  Carcinogenic, group 1
0,182  0,170  CYP2D6 inhibitor
0,108  0,097  Antiviral (Influenza B)
0,039  0,029  Membrane dipeptidase inhibitor
0,018  0,009  Vitamin D receptor agonist
0,109  0,100  Antimutagenic
0,065  0,056  Exportin-1 inhibitor
0,128  0,119  Uterine stimulant
0,083  0,075  Thioredoxin inhibitor
0,143  0,136  Phobic disorders treatment
0,079  0,071  Estrogen-related receptor beta agonist
0,140  0,132  Antimitotic
0,045  0,038  Glucose-6-phosphate isomerase inhibitor
0,213  0,205  Antiprotozoal
0,092  0,085  Toll-Like receptor 4 antagonist
0,075  0,069  Antidote, organophosphates
0,206  0,200  GABA C receptor rho-3 antagonist
0,017  0,012  5-Alpha-reductase 1 inhibitor
0,042  0,037  Opioid mu receptor agonist
0,165  0,160  5 Hydroxytryptamine release stimulant
0,032  0,028  Retinoid X alpha receptor antagonist
0,025  0,021  Nicotinic acid receptor 2 antagonist
0,043  0,038  Potassium channel Kv1.3 blocker
0,036  0,031  Retinoid X receptor antagonist
0,017  0,012  Telomerase stimulant
0,075  0,071  Inducible nitric-oxide synthase inhibitor
0,020  0,016  Retinoid X beta receptor antagonist
0,163  0,159  Antiosteoporotic
0,030  0,027  Glutamate (mGluR3) agonist
0,009  0,007  Progesterone receptor A antagonist
0,049  0,047  Nicotinic alpha3beta2 receptor antagonist
0,020  0,019  Elastase 2A inhibitor
0,020  0,019  Elastase 2 inhibitor
0,146  0,145  CYP2B6 inhibitor
0,059  0,058  Phosphofructokinase-1 inhibitor
0,058  0,058  Acetylcholine M5 receptor agonist

